C

Curaleaf

Cannabis cultivation, processing, and retailing

Overview

Curaleaf is a cannabis company that grows, processes, and sells cannabis products for medical and recreational use. It offers items such as tinctures, flowers, and edibles, and uses encapsulation technology to improve product absorption and effectiveness. Customers can buy at dispensaries or online, and the company also provides medical consultations and guidance services. Differentiators include its vertically integrated model (cultivation, processing, and retail) and its social responsibility efforts, such as the B NOBLE program that supports individuals with cannabis-related non-violent charges. The company’s goal is to provide reliable cannabis products and related services to a wide range of customers while advancing responsible access and advocacy through programs like B NOBLE.

Work here?Claim your company

About Curaleaf

Simplify's Rating
Why Curaleaf is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Social ImpactBiotechnologyHealthcareConsumer Goods

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Stamford, CT

Founded

2010

Get referred to Curaleaf

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • Q2 2026 revenue reached $340.1 million, up 10%, with $12.5 million net income.
  • September 2026 Aurora bid targets Germany's medical cannabis market and four 20 Pharma distribution.
  • Curaleaf's Boston opening and Florida expansions add stores, patients, and brand shelf space now.

What critics are saying

  • Curaleaf carried $611.5 million debt against $107 million cash on June 30, 2026.
  • Aurora's board can stall Curaleaf's $4 hostile bid until the December 1, 2026 deadline.
  • Federal illegality keeps Curaleaf exposed to appeals, contract fights, and banking fragility across jurisdictions.

What makes Curaleaf unique

  • Curaleaf spans U.S. dispensaries and EU-GMP manufacturing across Germany, Spain, Portugal, and Canada.
  • On September 2026, Curaleaf became Spain's first standardized medicinal cannabis registrar under Royal Decree 903/2025.
  • Florida remains Curaleaf's scale moat: 77 dispensaries statewide and 178 nationwide on September 4, 2026.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$2.5B

Above

Industry Average

Funded Over

12 Rounds

Post IPO Debt funding comparison data is currently unavailable. We're working to provide this information soon!
Post IPO Debt Funding Comparison Coming Soon

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Paid Vacation
  • Parental Leave
  • 401(k) Retirement Plan
  • Life Insurance
  • Disability Insurance

Stock Price

Growth & Insights and Company News

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Nov 3rd, 2026
Curaleaf Q3 revenue rises 11% to a record $353M, with adjusted EBITDA of $78M

Curaleaf reported record third-quarter 2026 net revenue of $353 million, up 11% from a year earlier. Domestic revenue grew 8% and international revenue rose 28% to $59 million. Adjusted EBITDA was $78 million, a 22% margin, while adjusted gross margin was 49%. The company posted a net loss of $37.4 million from continuing operations and ended the quarter with $105 million in cash. Curaleaf opened two Florida dispensaries in the quarter, bringing its operated and managed total to 188. It also launched an offer to buy Aurora Cannabis, which later announced an alternative merger with Organigram. Curaleaf is weighing its options. It still targets about $150 million in operating cash flow for the year.

PR Newswire
Nov 2nd, 2026
Curaleaf buys stake in Boone Town Provisions, growing New Jersey presence to four dispensaries

Curaleaf has acquired an equity stake and certain operating rights in Boone Town Provisions, a dispensary in Boonton, New Jersey. The deal brings the cannabis company to four dispensaries in the state and 191 nationwide. Curaleaf expects the store to add to earnings immediately. Chairman and chief executive officer Boris Jordan called it "one of the top-performing dispensaries in New Jersey" and said the interest was bought at an attractive valuation. The company did not disclose the price. The 6,400-square-foot store opened in July 2024 on a busy stretch of Myrtle Avenue with few dispensaries nearby. Curaleaf's other New Jersey stores are in Bellmawr, Bordentown, and Edgewater Park.

Yahoo Finance
Oct 27th, 2026
Curaleaf says Alberta ruling doesn't change debate as it defends 86% premium Aurora bid

Curaleaf Holdings has pushed back after the Alberta Securities Commission (ASC) ruled on Aurora Cannabis' at-the-market (ATM) share program, saying the decision does not change the debate over its takeover bid. Chief executive officer Boris Jordan said Aurora shareholders still face unanswered questions, including why Aurora issued shares under the ATM below the original offer price after Curaleaf signalled a bid. Curaleaf says its enhanced offer of about $5.00 a share is an 86% premium to Aurora's unaffected average price of about $2.75. It says Aurora sold shares as low as $2.56 under the ATM, and that it remains excluded from customary diligence. Curaleaf says a combined company would operate in 17 countries, with more than $1.5 billion in last-twelve-month revenue and at least $40 million in expected annual cost synergies.

PR Newswire
Sep 15th, 2026
Curaleaf urges Aurora shareholders to accept 45% premium takeover offer

Curaleaf Holdings has issued a letter urging Aurora Cannabis shareholders to accept its takeover offer, which represents a 45% premium over Aurora's 30-day volume weighted average price. The acquisition would create a combined company operating across 17 countries with US$1.5 billion in last twelve-month revenue and nearly US$350 million of adjusted EBITDA. Curaleaf Chairman and CEO Boris Jordan framed the decision starkly, describing Aurora as "a shrinking business that is burning cash and getting less profitable by the day." The company expects at least US$40 million in annual cost synergies from the combination. Aurora has refused to engage with Curaleaf's proposal. Jordan announced a live shareholder Q&A session scheduled for 17 September to discuss the offer directly with Aurora investors.

Yahoo Finance
Sep 2nd, 2026
Curaleaf opens Boston dispensary near Downtown Crossing with expanded retail space

Curaleaf Holdings has opened a new cannabis dispensary in downtown Boston at 21 Milk St., near Downtown Crossing. The location opened on 4 September, offering patients expanded retail space and a broader selection of products. The dispensary will stock Curaleaf's portfolio of cannabis brands, including Dark Heart, Select, FIND, Anthem and Grassroots. Knowledgeable staff will assist customers in selecting products suited to their needs. A grand opening celebration is scheduled for 8 September, featuring in-store promotions, a Meet the Grower event, and brand activations. The store operates from 09:00 to 20:00 Monday through Saturday, and 09:00 to 18:00 on Sunday. The opening follows the closure of Curaleaf's former Provincetown dispensary.

Recently Posted Jobs

Sign up to get curated job recommendations

Curaleaf is Hiring for 185 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs